Results 261 to 270 of about 1,437,121 (388)
The immunology of atherosclerosis
A. Gisterå, G. Hansson
semanticscholar +1 more source
Objective Recent inflammatory bowel disease (IBD) treatment guidelines have recommended against NSAID use despite prevalent musculoskeletal symptoms and opioid overuse in this population. Given the discordance between changing national guidelines and potential clinical utility, we sought to assess national temporal trends in prescription NSAID and ...
Adam S. Mayer +5 more
wiley +1 more source
Correction: Editorial: Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance. [PDF]
Spada S, Ganguly A.
europepmc +1 more source
Jacalin: A new laboratory tool in immunochemistry and cellular immunology
Pièrre Aucouturier +6 more
openalex +2 more sources
Assessment of Pain Types in Recently Diagnosed Patients With Inflammatory Arthritis
Objective Up to 40% of patients with inflammatory arthritis (IA) experience persistent pain, traditionally thought to be associated with a shift from peripherally to centrally mediated pain during the disease course in some patients. We assessed sensory profiles of recently diagnosed individuals with IA, hypothesizing that pain reported at this early ...
Zoe Rutter‐Locher +8 more
wiley +1 more source
Editorial: Cytokines, and biomarkers involved in the immunomodulation of pediatric cancers. [PDF]
Poggi A +4 more
europepmc +1 more source
Serum Soluble Mediator Signatures of Lupus Nephritis: Histologic Features and Response to Treatment
Objective Lupus nephritis (LN) management remains challenging, and novel noninvasive biomarkers are needed. This study quantified serum soluble mediators in the Accelerating Medicines Partnership (AMP) LN cohort to identify biomarkers of histologic features and treatment response.
Andrea Fava +48 more
wiley +1 more source
The impact of COVID-19 on the incidence of allergic diseases in the pediatric population: A retrospective cohort study from TriNetX United States collaborative network. [PDF]
Yong SB +9 more
europepmc +1 more source

